All News

guidelines.jpg (keep)

New ACR/NPF Guidelines for Management of Psoriatic Arthritis

d Jack Cush, MD

The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA) that provides evidence-based pharmacologic and non-pharmacologic recommendations and includes recommendations on other management issues inclu

Read Article
oa.cartilage.jpg

Dendrimer Nanocarrier Delivers IGF-1 to Degenerative Cartilage

d Jack Cush, MD

Researchers from MIT have developed a novel treatment for osteoarthritis (OA) by using dendrimer-based nanocarriers to deliver insulin-like growth factor 1 (IGF-1) to chondrocytes within joint cartilage and in animal models have shown when these nanocarriers injected into rat knees in models of O

Read Article
VitaminD.jpg

Limited Impact of Vitamin D Supplementation

d Jack Cush, MD

A systematic review of 81 studies on vitamin D concludes that vitamin D supplementation does not prevent fractures or falls, or have clinically meaningful effects on bone mineral density.

Read Article
psoriasis.NPF_.png

Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis

d Jack Cush, MD

Another, new Janus kinase 1 (JAK1) inhibitor is out with impressive data - this time its filgotinib, demonstrating its efficacy and safety two separate clinical trials of patients with psoriatic arthritis or ankylosing spondylitis.

Read Article
WIR.large_.jpg (keep)

RheumNow Podcast – To Needle or Not to Needle (11.30.18)

d Jack Cush, MD

Dr. Jack Cush updates the news and reports from the past week at RheumNow.com:

Read Article
Cohort study 56866 RA/PsA/AS patients compared 287 w/ multiple myeloma & 2760 matched controls - no difference in MM risk related to biologic, DMARD or NSAIDs. But compared to DMARD only pts, Biologic + DMARD users had a 48% lower risk of MM (OR 0.52) https://t.co/DsmvNXC9c9

Links:

Dr. John Cush RheumNow ( View Tweet)

Open source review Assessing Disease Activity in Psoriatic Arthritis: A Literature Review by Drs Tucker, Coates, Helliwell. How to assess arthritis, dactylitis, enthesitis, axial disease, skin & patient measures (PROMs). https://t.co/5SLwpeGbkn

Links:

Dr. John Cush RheumNow ( View Tweet)

Depression worsens back pain; increases healthcare costs. Medicare claims study 73,000 found 6,739 with back pain & 20% of these (1310) had depression. Annual healthcare costs substantially higher in LBP pts w/ depression ($13,153 vs $7,477, P < 0.001). https://t.co/rHqfWPTV7r

Links:

Dr. John Cush RheumNow ( View Tweet)

CDC reports that 40-47% of adults have had a flu vaccination in the past 12 months (higher in elderly (67%). https://t.co/RPmkTECeF7

Links:

Dr. John Cush RheumNow ( View Tweet)

Bisphosphonate safety review — risk of Atypical Femoral Fracture is 1/1000 and risk of osteonecrosis of the jaw is 1/10,000. One-third of IV zolendronic acid pts will have arthralgia/myalgias or flu like sxs. https://t.co/80xBkZlKgn

Links:

Dr. John Cush RheumNow ( View Tweet)

FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly and systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk; sadly this was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4

Links:

Dr. John Cush RheumNow ( View Tweet)

I prefer more slides with less data per slide rather than fewer slides jam packed with multiple miniscule figures #ASH18

John P. Leonard, MD JohnPLeonardMD ( View Tweet)

We are not only doctors for the elderly. Many of our patients are young or even children. Sometimes we treat banal conditions but also we manage severe & autoimmune disorders with systemic involvement. We use innovative therapies. Didn't you know us? We are the Rheumatologists

Emilio Martin Mola emartinmola ( View Tweet)

This is a great conference! https://t.co/GEDlj44jLE

Links:

Dr. John Cush RheumNow ( View Tweet)

2017 US life expectancy decreased for the 3rd year in a row. Drug overdoses & suicides lead the trend, resulting in earlier deaths and how long people live. Life expectancy dropped 78.7 yrs in 2016 to 78.6 yrs in 2017, with changes in men; not women https://t.co/gUParIkR6W

Links:

Dr. John Cush RheumNow ( View Tweet)

Dont Miss the Next Best Meeting in Rheumatology - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf

Links:

Dr. John Cush RheumNow ( View Tweet)

The RheumNow Podcast is Up! To Needle or Not to Needle; Watch https://t.co/pjYZh5LXzi or listent to the weekly news and review https://t.co/AmXgjki2dL

Links:

Dr. John Cush RheumNow ( View Tweet)

296 women with HTN during pregnancy (half/147 NSAID-exposed) - NSAID use was not associated with a significant change in BP (vs no NSAID) and there was no added need to start or increase BP meds in those on NSAIDS. https://t.co/csDljBJI3r

Links:

Dr. John Cush RheumNow ( View Tweet)

AstraZeneca today announced the FDA has granted Orphan Drug Status for Fasenra (benralizumab) for Eosinophilic Granulomatosis with Polyangiitis (EGPA). Fasenra is also approved for severe, eosinophilic asthma https://t.co/4ChX8D5Evx

Links:

Dr. John Cush RheumNow ( View Tweet)

×